_id
6910584dccc777a4e85d56df
Ticker
CYBN
Name
Cybin Inc
Exchange
NYSE MKT
Address
100 King Street West, Toronto, ON, Canada, M5X 1C9
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://cybin.com
Description
Cybin Inc., a clinical-stage neuropsychiatry company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions. It develops CYB003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and CYB004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders. The company also develops SPL028 injectable deuterated DMT completed phase 1 clinical intramuscular and intravenous trial; SPL026 for MDD; and CYB005, a phenethylamine derivative, which in preclinical stage to treat central nervous system, as well as has a research pipeline of investigational psychedelic-based compounds. It has a strategic partnership agreement with Segal Trials to support PARADIGM, a multinational pivotal phase 3 program evaluating CYB003 for the adjunctive treatment of major depressive disorder. The company is headquartered in Toronto, Canada.
Last Close
8
Volume
1192659
Current Price
7.73
Change
-0.39
Last Updated
2026-01-02T12:19:50.324Z
Image
data:image/webp;base64,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
Ipo Date
2019-09-13T00:00:00.000Z
Market Cap
408432064
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9306666666666666
Sentiment Sources
6
Rating
4.8
Target Price
48.0372
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
28894000
Operating Income
-28894000
Interest Expense
-
Pretax Income
-33722000
Net Income
-33722000
Eps
-1.3931330956857533
Dividends Per Share
-
Shares Outstanding
49894131
Income Tax Expense
-
EBITDA
-28865000
Operating Margin
-
Total Other Income Expense Net
-4828000
Cash
83752000
Short Term Investments
-
Receivables
4735000
Inventories
-
Total Current Assets
114581000
Property Plant Equipment
125000
Total Assets
181246000
Payables
18592554
Short Term Debt
-
Long Term Debt
28888000
Total Liabilities
42250000
Equity
138996000
Bs_currency_symbol
USD
Depreciation
29000
Change In Working Capital
-7062000
Cash From Operations
-34485000
Capital Expenditures
436000
Cash From Investing
-436000
Cash From Financing
27000
Net Change In Cash
-34940000
Cf_currency_symbol
USD
PE
-
PB
1.3461637948574061
ROE
-24.261129816685372
ROA
-18.605651986802467
FCF
-34921000
Fcf Percent
-
Piotroski FScore
0
Health Score
42
Deep Value Investing Score
5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
4.5
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
6.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
28894000
Quarters > 0 > income Statement > operating Income
-28894000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-33722000
Quarters > 0 > income Statement > net Income
-33722000
Quarters > 0 > income Statement > eps
-1.3931330956857533
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
24205871
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-28865000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-4828000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
83752000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
4735000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
114581000
Quarters > 0 > balance Sheet > property Plant Equipment
125000
Quarters > 0 > balance Sheet > total Assets
181246000
Quarters > 0 > balance Sheet > payables
18592554
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
28888000
Quarters > 0 > balance Sheet > total Liabilities
42250000
Quarters > 0 > balance Sheet > equity
138996000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-33722000
Quarters > 0 > cash Flow > depreciation
29000
Quarters > 0 > cash Flow > change In Working Capital
-7062000
Quarters > 0 > cash Flow > cash From Operations
-34485000
Quarters > 0 > cash Flow > capital Expenditures
436000
Quarters > 0 > cash Flow > cash From Investing
-436000
Quarters > 0 > cash Flow > cash From Financing
27000
Quarters > 0 > cash Flow > net Change In Cash
-34940000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-1.3931330956857533
Quarters > 0 > ratios > PB
1.3461637948574061
Quarters > 0 > ratios > ROE
-24.261129816685372
Quarters > 0 > ratios > ROA
-18.605651986802467
Quarters > 0 > ratios > FCF
-34921000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
24624000
Quarters > 1 > income Statement > operating Income
-24624000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-24613000
Quarters > 1 > income Statement > net Income
-24613000
Quarters > 1 > income Statement > eps
-1.0987359291559287
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
22401197
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-24586000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
11000
Quarters > 1 > income Statement > currency_symbol
CAD
Quarters > 1 > balance Sheet > cash
118692000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
4105000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
143650000
Quarters > 1 > balance Sheet > property Plant Equipment
82000
Quarters > 1 > balance Sheet > total Assets
210813000
Quarters > 1 > balance Sheet > payables
19822786
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
44500000
Quarters > 1 > balance Sheet > total Liabilities
59053000
Quarters > 1 > balance Sheet > equity
151760000
Quarters > 1 > balance Sheet > currency_symbol
CAD
Quarters > 1 > cash Flow > net Income
-24613000
Quarters > 1 > cash Flow > depreciation
38000
Quarters > 1 > cash Flow > change In Working Capital
-3775000
Quarters > 1 > cash Flow > cash From Operations
-29548000
Quarters > 1 > cash Flow > capital Expenditures
231000
Quarters > 1 > cash Flow > cash From Investing
-221000
Quarters > 1 > cash Flow > cash From Financing
54633000
Quarters > 1 > cash Flow > net Change In Cash
24770000
Quarters > 1 > cash Flow > currency_symbol
CAD
Quarters > 1 > ratios > PE
-1.0987359291559287
Quarters > 1 > ratios > PB
1.1410203796125462
Quarters > 1 > ratios > ROE
-16.21837111228255
Quarters > 1 > ratios > ROA
-11.675276192644667
Quarters > 1 > ratios > FCF
-29779000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
33272000
Quarters > 2 > income Statement > operating Income
-33272000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-30579000
Quarters > 2 > income Statement > net Income
-30579000
Quarters > 2 > income Statement > eps
-1.4149932366849316
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
21610704
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
1252000
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
135022000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
5885000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
165972000
Quarters > 2 > balance Sheet > property Plant Equipment
141000
Quarters > 2 > balance Sheet > total Assets
258618000
Quarters > 2 > balance Sheet > payables
21418000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
21418000
Quarters > 2 > balance Sheet > equity
237200000
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
-50579000
Quarters > 2 > cash Flow > depreciation
62000
Quarters > 2 > cash Flow > change In Working Capital
8563000
Quarters > 2 > cash Flow > cash From Operations
-21113000
Quarters > 2 > cash Flow > capital Expenditures
1084000
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
20981000
Quarters > 2 > cash Flow > net Change In Cash
-1268000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-1.4149932366849316
Quarters > 2 > ratios > PB
0.7042611379426644
Quarters > 2 > ratios > ROE
-12.891652613827992
Quarters > 2 > ratios > ROA
-11.824002969630884
Quarters > 2 > ratios > FCF
-22197000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
31304000
Quarters > 3 > income Statement > operating Income
-31304000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-10542000
Quarters > 3 > income Statement > net Income
-10542000
Quarters > 3 > income Statement > eps
-0.5270736463176842
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
20001000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-31172000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
20762000
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
136290000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
5583000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
167691000
Quarters > 3 > balance Sheet > property Plant Equipment
185000
Quarters > 3 > balance Sheet > total Assets
253546000
Quarters > 3 > balance Sheet > payables
13306000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
13306000
Quarters > 3 > balance Sheet > equity
240240000
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
-10542000
Quarters > 3 > cash Flow > depreciation
132000
Quarters > 3 > cash Flow > change In Working Capital
-924000
Quarters > 3 > cash Flow > cash From Operations
-27124000
Quarters > 3 > cash Flow > capital Expenditures
303000
Quarters > 3 > cash Flow > cash From Investing
-303000
Quarters > 3 > cash Flow > cash From Financing
-179000
Quarters > 3 > cash Flow > net Change In Cash
-18028000
Quarters > 3 > cash Flow > currency_symbol
CAD
Quarters > 3 > ratios > PE
-0.5270736463176842
Quarters > 3 > ratios > PB
0.6435553196803196
Quarters > 3 > ratios > ROE
-4.388111888111888
Quarters > 3 > ratios > ROA
-4.157825404463096
Quarters > 3 > ratios > FCF
-27427000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
41
Annuals > 0 > quarter
2025-03-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
143147000
Annuals > 0 > income Statement > operating Income
-143147000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-113137000
Annuals > 0 > income Statement > net Income
-113137000
Annuals > 0 > income Statement > eps
-0.6101372609569259
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
185428767
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-142672000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
30010000
Annuals > 0 > income Statement > currency_symbol
CAD
Annuals > 0 > balance Sheet > cash
135022000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
5885000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
165972000
Annuals > 0 > balance Sheet > property Plant Equipment
141000
Annuals > 0 > balance Sheet > total Assets
258618000
Annuals > 0 > balance Sheet > payables
21418000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
21418000
Annuals > 0 > balance Sheet > equity
237200000
Annuals > 0 > balance Sheet > currency_symbol
CAD
Annuals > 0 > cash Flow > net Income
-113137000
Annuals > 0 > cash Flow > depreciation
475000
Annuals > 0 > cash Flow > change In Working Capital
-9793000
Annuals > 0 > cash Flow > cash From Operations
-101300000
Annuals > 0 > cash Flow > capital Expenditures
1966000
Annuals > 0 > cash Flow > cash From Investing
-1966000
Annuals > 0 > cash Flow > cash From Financing
20197000
Annuals > 0 > cash Flow > net Change In Cash
-73970000
Annuals > 0 > cash Flow > currency_symbol
CAD
Annuals > 0 > ratios > PE
-0.6101372609569259
Annuals > 0 > ratios > PB
6.3946345449409785
Annuals > 0 > ratios > ROE
-47.6968802698145
Annuals > 0 > ratios > ROA
-43.74676163298765
Annuals > 0 > ratios > FCF
-103266000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
26
Annuals > 1 > quarter
2024-03-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
424000
Annuals > 1 > income Statement > gross Profit
-424000
Annuals > 1 > income Statement > operating Expenses
78836000
Annuals > 1 > income Statement > operating Income
-78836000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-78080000
Annuals > 1 > income Statement > net Income
-78080000
Annuals > 1 > income Statement > eps
-0.4210781383235968
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
185428767
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-78576000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
756000
Annuals > 1 > income Statement > currency_symbol
CAD
Annuals > 1 > balance Sheet > cash
208992000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
4476000
Annuals > 1 > balance Sheet > inventories
-4476000
Annuals > 1 > balance Sheet > total Current Assets
218536000
Annuals > 1 > balance Sheet > property Plant Equipment
547000
Annuals > 1 > balance Sheet > total Assets
302023000
Annuals > 1 > balance Sheet > payables
9805000
Annuals > 1 > balance Sheet > short Term Debt
291000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
10096000
Annuals > 1 > balance Sheet > equity
291927000
Annuals > 1 > balance Sheet > currency_symbol
CAD
Annuals > 1 > cash Flow > net Income
-78080000
Annuals > 1 > cash Flow > depreciation
424000
Annuals > 1 > cash Flow > change In Working Capital
-5027000
Annuals > 1 > cash Flow > cash From Operations
-68908000
Annuals > 1 > cash Flow > capital Expenditures
710000
Annuals > 1 > cash Flow > cash From Investing
6922000
Annuals > 1 > cash Flow > cash From Financing
254507000
Annuals > 1 > cash Flow > net Change In Cash
192359000
Annuals > 1 > cash Flow > currency_symbol
CAD
Annuals > 1 > ratios > PE
-0.4210781383235968
Annuals > 1 > ratios > PB
5.195844557235199
Annuals > 1 > ratios > ROE
-26.7464126305549
Annuals > 1 > ratios > ROA
-25.852335749264128
Annuals > 1 > ratios > FCF
-69618000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2023-03-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
251000
Annuals > 2 > income Statement > gross Profit
-251000
Annuals > 2 > income Statement > operating Expenses
51518000
Annuals > 2 > income Statement > operating Income
-51518000
Annuals > 2 > income Statement > interest Expense
7453000
Annuals > 2 > income Statement > pretax Income
-47490000
Annuals > 2 > income Statement > net Income
-40037000
Annuals > 2 > income Statement > eps
-0.21591552561897007
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
185429000
Annuals > 2 > income Statement > income Tax Expense
-7453000
Annuals > 2 > income Statement > EBITDA
-51285000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
4028000
Annuals > 2 > income Statement > currency_symbol
CAD
Annuals > 2 > balance Sheet > cash
53641000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
3050000
Annuals > 2 > balance Sheet > inventories
1271000
Annuals > 2 > balance Sheet > total Current Assets
58355000
Annuals > 2 > balance Sheet > property Plant Equipment
491000
Annuals > 2 > balance Sheet > total Assets
84063000
Annuals > 2 > balance Sheet > payables
5663000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
7908000
Annuals > 2 > balance Sheet > equity
76155000
Annuals > 2 > balance Sheet > currency_symbol
CAD
Annuals > 2 > cash Flow > net Income
-67631000
Annuals > 2 > cash Flow > depreciation
168000
Annuals > 2 > cash Flow > change In Working Capital
213000
Annuals > 2 > cash Flow > cash From Operations
-45207000
Annuals > 2 > cash Flow > capital Expenditures
520000
Annuals > 2 > cash Flow > cash From Investing
-770000
Annuals > 2 > cash Flow > cash From Financing
35777000
Annuals > 2 > cash Flow > net Change In Cash
-10385000
Annuals > 2 > cash Flow > currency_symbol
CAD
Annuals > 2 > ratios > PE
-0.21591552561897007
Annuals > 2 > ratios > PB
19.917395049569954
Annuals > 2 > ratios > ROE
-52.57304182259864
Annuals > 2 > ratios > ROA
-47.62737470706494
Annuals > 2 > ratios > FCF
-45727000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
27
Annuals > 3 > quarter
2022-03-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
168000
Annuals > 3 > income Statement > gross Profit
-168000
Annuals > 3 > income Statement > operating Expenses
63838000
Annuals > 3 > income Statement > operating Income
-63838000
Annuals > 3 > income Statement > interest Expense
241000
Annuals > 3 > income Statement > pretax Income
-67631000
Annuals > 3 > income Statement > net Income
-71424000
Annuals > 3 > income Statement > eps
-0.4269548739591241
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
167287000
Annuals > 3 > income Statement > income Tax Expense
3793000
Annuals > 3 > income Statement > EBITDA
-63670000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-3793000
Annuals > 3 > income Statement > currency_symbol
CAD
Annuals > 3 > balance Sheet > cash
64026000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
2102000
Annuals > 3 > balance Sheet > inventories
-212000
Annuals > 3 > balance Sheet > total Current Assets
66484000
Annuals > 3 > balance Sheet > property Plant Equipment
557000
Annuals > 3 > balance Sheet > total Assets
92112000
Annuals > 3 > balance Sheet > payables
5262000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
5994000
Annuals > 3 > balance Sheet > equity
86118000
Annuals > 3 > balance Sheet > currency_symbol
CAD
Annuals > 3 > cash Flow > net Income
-32220000
Annuals > 3 > cash Flow > depreciation
49000
Annuals > 3 > cash Flow > change In Working Capital
-1267000
Annuals > 3 > cash Flow > cash From Operations
-19027000
Annuals > 3 > cash Flow > capital Expenditures
231000
Annuals > 3 > cash Flow > cash From Investing
-1189000
Annuals > 3 > cash Flow > cash From Financing
35777000
Annuals > 3 > cash Flow > net Change In Cash
62481000
Annuals > 3 > cash Flow > currency_symbol
CAD
Annuals > 3 > ratios > PE
-0.4269548739591241
Annuals > 3 > ratios > PB
15.889914535869387
Annuals > 3 > ratios > ROE
-82.93736501079914
Annuals > 3 > ratios > ROA
-77.54038561750912
Annuals > 3 > ratios > FCF
-19258000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
26
Valuation > metrics > PE
-1.3931330956857533
Valuation > metrics > PB
1.3461637948574061
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-24.261129816685372
Profitability > metrics > ROA
-29.430708407153016
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.3039655817433595
Risk > metrics > Interest Coverage
-5.948939674696315
Risk > final Score
36
Risk > verdict
High
Liquidity > metrics > Current Ratio
6.162735899543441
Liquidity > metrics > Quick Ratio
6.162735899543441
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-3588
Prev Risks > 1
-46
Prev Risks > 2
54
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:41:18.036Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-13
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-1.39
Earnings History > 0 > eps Estimate
-1.3288
Earnings History > 0 > eps Difference
-0.0612
Earnings History > 0 > surprise Percent
-4.6057
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-07-01
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.46
Earnings History > 1 > eps Estimate
-0.0248
Earnings History > 1 > eps Difference
-1.4352
Earnings History > 1 > surprise Percent
-5787.0968
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-03-31
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-1.46
Earnings History > 2 > eps Estimate
-1.23
Earnings History > 2 > eps Difference
-0.23
Earnings History > 2 > surprise Percent
-18.6992
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-11
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.53
Earnings History > 3 > eps Estimate
-0.0263
Earnings History > 3 > eps Difference
-0.5037
Earnings History > 3 > surprise Percent
-1915.2091
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-13
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
CAD
Earnings History > 4 > eps Actual
-2.86
Earnings History > 4 > eps Estimate
-0.0248
Earnings History > 4 > eps Difference
-2.8352
Earnings History > 4 > surprise Percent
-11432.2581
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
CAD
Earnings History > 5 > eps Actual
-0.02
Earnings History > 5 > eps Estimate
-0.02
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
0
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-06-25
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
CAD
Earnings History > 6 > eps Actual
-0.0328
Earnings History > 6 > eps Estimate
-0.03
Earnings History > 6 > eps Difference
-0.0028
Earnings History > 6 > surprise Percent
-9.3333
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-14
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
CAD
Earnings History > 7 > eps Actual
-0.09
Earnings History > 7 > eps Estimate
-0.04
Earnings History > 7 > eps Difference
-0.05
Earnings History > 7 > surprise Percent
-125
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-13
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
CAD
Earnings History > 8 > eps Actual
-0.05
Earnings History > 8 > eps Estimate
-0.05
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
0
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-14
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
CAD
Earnings History > 9 > eps Actual
-0.07
Earnings History > 9 > eps Estimate
-0.06
Earnings History > 9 > eps Difference
-0.01
Earnings History > 9 > surprise Percent
-16.6667
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-06-27
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
CAD
Earnings History > 10 > eps Actual
-0.07
Earnings History > 10 > eps Estimate
-0.06
Earnings History > 10 > eps Difference
-0.01
Earnings History > 10 > surprise Percent
-16.6667
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-02-16
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
CAD
Earnings History > 11 > eps Actual
-0.06
Earnings History > 11 > eps Estimate
-0.06
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
0
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
CAD
Earnings History > 12 > eps Actual
-0.06
Earnings History > 12 > eps Estimate
-0.07
Earnings History > 12 > eps Difference
0.01
Earnings History > 12 > surprise Percent
14.2857
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-08
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
CAD
Earnings History > 13 > eps Actual
-0.07
Earnings History > 13 > eps Estimate
-0.09
Earnings History > 13 > eps Difference
0.02
Earnings History > 13 > surprise Percent
22.2222
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-06-22
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
CAD
Earnings History > 14 > eps Actual
-0.1
Earnings History > 14 > eps Estimate
-0.1
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
0
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-02-10
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
CAD
Earnings History > 15 > eps Actual
-0.1
Earnings History > 15 > eps Estimate
-0.1
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
0
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-15
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
CAD
Earnings History > 16 > eps Actual
-0.11
Earnings History > 16 > eps Estimate
-0.1
Earnings History > 16 > eps Difference
-0.01
Earnings History > 16 > surprise Percent
-10
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-13
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
CAD
Earnings History > 17 > eps Actual
-0.09
Earnings History > 17 > eps Estimate
-0.05
Earnings History > 17 > eps Difference
-0.04
Earnings History > 17 > surprise Percent
-80
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-06-28
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
CAD
Earnings History > 18 > eps Actual
-0.08
Earnings History > 18 > eps Estimate
-0.05
Earnings History > 18 > eps Difference
-0.03
Earnings History > 18 > surprise Percent
-60
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-02-16
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
CAD
Earnings History > 19 > eps Actual
-0.1
Earnings History > 19 > eps Estimate
-0.03
Earnings History > 19 > eps Difference
-0.07
Earnings History > 19 > surprise Percent
-233.3333
Cybin Inc., a clinical-stage neuropsychiatry company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions. It develops CYB003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and CYB004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders. The company also develops SPL028 injectable deuterated DMT completed phase 1 clinical intramuscular and intravenous trial; SPL026 for MDD; and CYB005, a phenethylamine derivative, which in preclinical stage to treat central nervous system, as well as has a research pipeline of investigational psychedelic-based compounds. It has a strategic partnership agreement with Segal Trials to support PARADIGM, a multinational pivotal phase 3 program evaluating CYB003 for the adjunctive treatment of major depressive disorder. The company is headquartered in Toronto, Canada.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AHow Cybin Inc. (CYBN) Affects Rotational Strategy Timing Stock Traders Daily
Read more →Cybin (CYBN) Is Down 9.8% After Launching US$100M At-The-Market Equity Program - What's Changed simplywall.st
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$48.0372
Analyst Picks
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Cybin Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-1.39
EPS Estimate
-1.3288
EPS Difference
-0.0612
Surprise Percent
-4.6057%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.